We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Hypersegmented Neutrophils Associated with Reduced Lung Function

By LabMedica International staff writers
Posted on 19 Feb 2019
Print article
Image: A representative photomicrograph of bronchial lavage (BL) cytospin of obstructive airway disease participants Subsets of neutrophils characterized as per number of lobes in their nucleus (Photo courtesy of University of Newcastle).
Image: A representative photomicrograph of bronchial lavage (BL) cytospin of obstructive airway disease participants Subsets of neutrophils characterized as per number of lobes in their nucleus (Photo courtesy of University of Newcastle).
Neutrophils are phagocytic innate immune cells, which patrol the blood vessels and become activated in response to inflammatory triggers. Activation results in neutrophil migration to the site of infection, where pathogens can be eliminated by phagocytosis or NETosis.

Inflammation characterized by airway neutrophilia is reported in many cases of chronic obstructive airway disease. This includes 20% to 30% cases of asthma, more than 40% cases of chronic obstructive pulmonary disease (COPD), and 70% cases of non-cystic fibrosis (CF) bronchiectasis.

Scientists at the University of Newcastle (Callaghan, Australia) and their associates recruited adults who were undergoing bronchoscopy either for medical purposes or were undergoing a surgical procedure that involved endotracheal intubation and had spirometry results. Participants included 78 adults with obstructive airway disease comprised of 39 with stable asthma, 20 with COPD and 19 diagnosed as bronchiectasis and 20 healthy controls.

Spirometry was performed using an Easy One Spirometer. Flexible bronchoscopy was performed and a fraction of the bronchial lavage (BL) was sent for microbial detection while the rest was processed. The BL was centrifuged and the cell pellet was resuspended in phosphate buffered saline to the concentration of 1×106/mL and cellular cytospins were prepared. The cytospins were stained with May-Grünwald Giemsa and a differential cell count of 400 non-squamous cells was performed.

The team reported that the numbers of hypersegmented neutrophils were significantly elevated in participants with airway disease compared with healthy controls. Both the number and the proportion of hypersegmented neutrophils were highest in COPD participants (median (Q1–Q3) of 1,073.6 (258.8–2,742) × 102/mL and 24.5 (14.0–46.5) %, respectively). An increased proportion of hypersegmented neutrophils in airway disease participants was significantly associated with lower forced expiratory volume in 1 s/forced vital capacity percent. In participants with COPD, the proportion of hypersegmented neutrophils was positively associated with proportion of eosinophils and negatively associated with cell viability.

The authors concluded that the presence of three morphologically different subsets of neutrophils in the airways of healthy and obstructive airway disease participants, that is, asthma, COPD and bronchiectasis. The increased proportion of hypersegmented neutrophils in the airways of obstructive airway disease participants was associated with reduced lung function of these participants. The proportion of hypersegmented neutrophils was highest in COPD participants in comparison to all other groups. The study was published on January 28, 2019, in the journal BMJ OPEN.

Related Links:
University of Newcastle

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.